Trump Approves Final Plan to Import Drugs From Canada ‘for a Fraction of the Price’

Trump Approves Final Plan to Import Drugs From Canada ‘for a Fraction of the Price’

President Donald Trump, outlining his “America First Health Plan” on Thursday, announced that his administration will allow the importation of prescription drugs from Canada.
The final plan clears the way for Florida and other states to implement a program bringing medications across the border, despite the strong objections of drugmakers and the Canadian government.
But it does not allow states to import biologic drugs, including insulin.
Florida, the biggest swing state in the presidential election, is one of six states to pass laws seeking federal approval to import drugs. Trump’s announcement came the same day counties in Florida began sending out vote-by-mail ballots.
Florida Gov. Ron DeSantis, a close ally of the president’s, is a strong advocate of importing drugs. His administration has already advertised for a contractor to run the state program and is expected to announce Tuesday which companies have bid for the three-year, $30 million state contract.
Congress has allowed drug importation since 2003 but only if the secretary of the Department of Health and Human Services certified it is safe. That had never occurred until Secretary Alex Azar did it Wednesday, according to a letter he wrote to congressional leaders.
Implementation under the administration’s final rule “poses no additional risk to the public’s health and safety and will result in a significant reduction in the cost of covered products to the American consumer,” Azar said in the letter KHN obtained Thursday.
The rule noted, however, that HHS is unable to make any estimates about savings because it doesn’t know which drugs will be imported.
Prices are cheaper north of the border because Canada limits how much drugmakers can charge for medicines. The United States lets the free market dictate drug prices.
Even though insulin is not included among the drugs covered by the rule, the Trump administration Thursday issued a request for proposals seeking plans from private companies on how insulin could be safely brought in from other countries and made available to consumers at a lower cost than products here. The request specified it would have to be insulin that was once in the United States and sent to other nations before being brought back.
The pharmaceutical industry has long fought efforts on drug importation, arguing that it would disrupt the nation’s supply chain and make it easier for unsafe or counterfeit medications to enter the market.
“We are reviewing the final rule and guidance that were released; however, we continue to have grave concerns with drug importation that exposes Americans unnecessarily to the dangers of counterfeit or adulterated drugs,” said a spokesperson for the Pharmaceutical Research and Manufacturers of America, an industry trade group. “It is alarming that the administration chose to pursue a policy that threatens public health at the same time that we are fighting a global pandemic.”
Drugmakers have suggested in the past that they might try to stop such a policy through a lawsuit.
Trump has dangled his drug importation plan in campaign speeches over the past year — and again on Thursday in North Carolina during a speech that provided a litany of his promises on health care.
“We will finally allow the safe and legal importation of drugs from Canada,” Trump said. States “can go to Canada and buy your drugs for a fraction of the price” in the U.S.
“This will be a game changer for American seniors,” Trump said. “We’re doing it very, very quickly.”
The administration proposed the regulation in December. The final rule says it takes effect in 60 days.
But individuals will not be allowed to import drugs on their own, Azar said in his letter. Instead, they will have to rely on programs run by states.
Nonetheless, officials said they are interested in studying options for consumers to benefit from importation. The administration Thursday issued another request for proposals to set up a system that would allow U.S. consumers to import drugs through local pharmacies, a senior HHS official said Friday on a call with reporters.
For decades, Americans have been buying drugs from Canada for personal use — either by driving over the border, ordering medication on the internet or using storefronts that connect them to foreign pharmacies. Though the practice is illegal, the FDA has generally permitted purchases for individual use.
About 4 million Americans import medicines for personal use each year, and about 20 million say they or someone in their household has done so because prices are much lower in other countries, according to surveys.
The practice has been especially common in retiree-rich Florida, where more than a dozen stores help consumers make the purchases and where numerous cities, counties and school districts assist employees with the transactions.
The administration envisions a system in which a Canadian-licensed wholesaler buys from a manufacturer of drugs approved for sale in Canada and exports the drugs to a U.S. wholesaler/importer under contract to a state.
Florida’s legislation — approved in 2019 — would set up two importation programs. The first would focus on getting drugs for state programs such as Medicaid, the Department of Corrections and county health departments. State officials said they expect the program to save the state about $150 million annually.
The second program would be geared to the broader state population.
The HHS final rule said the government will “in the future” allow pharmacists to import drugs from Canada, a provision that matches the law approved by Florida in 2019.
But pharmacists in Florida and across the country oppose drug importation, saying they don’t think it will ensure that counterfeit drugs are kept out of the U.S. market.
The Canadian government told HHS last spring that the country doesn’t have enough drugs to spare and that the Trump plan would only worsen shortages of medicines there. It argues that Canada’s pharmaceutical market is too small to have any real impact on American prices. Canada represents 2% of the global pharmaceutical consumption, compared to the U.S.’s 44%.
“We remain focused on ensuring Canadians can access the medication they need,” Cole Davidson, a spokesman for Canada’s Health Minister Patty Hadju, said Friday.
The final rule said state importation programs will have the flexibility to decide which drugs to import and in what quantities.
The rule also makes clear that drug manufacturers will have to provide importers with documentation guaranteeing the medications are the same drugs as those already sold in the United States. HHS could set up regulations that require drugmakers to comply. Importers will have to send drugs to labs to certify their authenticity.
In addition to Florida, the other states seeking federal permission to buy drugs from Canada are Colorado, Maine, New Hampshire, New Mexico and Vermont.
Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.USE OUR CONTENTThis story can be republished for free (details).

It’s a tried-and-true campaign strategy. Candidates go on the attack, claiming their opponent will do harm to Medicare. After all, people 65 and older are good about making it to the polls on Election Day. These voters are also generally motivated to protect the federal health insurance program for seniors. It’s no surprise, then, that in an ad released this month, former Vice President Joe Biden’s campaign played the Medicare card.
Molly Wiese estaba perpleja. Sus padres y hermanos viven en el sur de California, y Wiese, abogada de 35 años, ha viajado cada Navidad desde que se mudó a Minnesota en 2007. Por la pandemia, Wiese pensó que esta vez sería más prudente quedarse. Pero en junio, el padre de Wiese fue diagnosticado con cáncer en estadio 4 y la familia teme que éstas sean sus últimas fiestas. ¿Debería volar con su esposo y sus dos hijos pequeños a California, poniendo a su padre inmunodeprimido en riesgo de COVID-19? ¿O quedarse en casa y perderse la oportunidad de crear recuerdos de estas fiestas?
During the final presidential debate, President Donald Trump claimed that 180 million people would lose their private health insurance to socialized medicine if the Democratic presidential nominee, former Vice President Joe Biden, is elected president. “They have 180 million people, families under what he wants to do, which will basically be socialized medicine — you won’t even have a choice — they want to terminate 180 million plans,” said Trump.
In the second and final debate of the 2020 presidential race, President Donald Trump and former Vice President Joe Biden sparred over Trump’s handling of the pandemic and Biden’s plan to reform health care. In stark contrast to the first debate, there was more policy talk. There was also less interrupting. Trump said a COVID-19 vaccine is “ready” and will be announced “within weeks,” shortly before conceding that it is “not a guarantee.” Biden said Trump still has no comprehensive plan to deal with the pandemic, even as case counts continue to climb. “We’re about to go into a dark winter, and...
COVID-19 cases are surging in rural places across the Mountain States and Midwest, and when it hits health care workers, ready reinforcements aren’t easy to find. In Montana, pandemic-induced staffing shortages have shuttered a clinic in the state’s capital, led a northwestern regional hospital to ask employees exposed to COVID-19 to continue to work and emptied a health department 400 miles to the east.
Molly Wiese was truly stumped. Her parents and siblings live in Southern California, and Wiese, a 35-year-old lawyer, has returned home every Christmas since she moved to Minnesota in 2007. Because of the pandemic, Wiese thought it would be wiser to stay put for once. But in June, Wiese’s father was diagnosed with stage 4 cancer, and they feared this could be his final holiday season. Should she fly with her husband and two young sons to California, putting her immunocompromised father at risk of COVID-19? Or stay home and miss out on making treasured holiday memories with her parents and...
KHN chief Washington correspondent Julie Rovner discussed the impact of the election and the upcoming Supreme Court challenge on the Affordable Care Act with New Hampshire Public Radio’s “The Exchange” and WNYC’s “The Brian Lehrer Show” on Wednesday. Rovner also spoke with Newsy’s “Morning Rush” on Thursday about the roles of health care and COVID-19 in the presidential campaign.
This story also ran on Fortune. It can be republished for free.
Can’t see the audio player? Click here to listen on SoundCloud. For the first time in a long time, there is some good news about the coronavirus pandemic: Although cases continue to climb, fewer people seem to be dying. And there are fewer cases than expected among younger pupils in schools with in-person learning. But the bad news continues as well — including a push for “herd immunity” that could result in the deaths of millions of Americans.
Frente a una pandemia, un desempleo sin precedentes y unos costos inciertos para los tratamientos de COVID-19, las aseguradoras que venden planes médicos en los mercados establecidos por la Ley de Cuidado de Salud a Bajo Precio (ACA) reaccionaron, en general, con sólo aumentos modestos de las primas para 2021. “Lo que resulta fascinante es que las aseguradoras, en general, no proyectan el impacto de la pandemia en sus primas para 2021”, dijo Sabrina Corlette, profesora del Centro de Reformas de Seguros de Salud de la Universidad de Georgetown, en Washington, D.C
Si realmente queremos detener la propagación del coronavirus a medida que se acerca el invierno y esperamos una vacuna, aquí una idea: el gobierno debería pagar a los bares, y a muchos restaurantes y lugares de eventos, para que cierren durante algunos meses. Puede sonar radical, pero tiene sentido científico e incluso tiene un precedente político. Pagamos a los agricultores para que no cultiven algunos campos (en teoría, para proteger el medio ambiente), así que ¿por qué no compensar a los propietarios para que cierren sus negocios para proteger la salud pública?
SACRAMENTO, Calif. — In an election year dominated by a chaotic presidential race and splashy statewide ballot initiative campaigns, Californians are being asked to weigh in on the value of stem cell research — again. Proposition 14 would authorize the state to borrow $5.5 billion to keep financing the California Institute for Regenerative Medicine (CIRM), currently the second-largest funder of stem cell research in the world. Factoring in interest payments, the measure could cost the state roughly $7.8 billion over about 30 years, according to an estimate from the nonpartisan state...
If we really want to stem the spread of the coronavirus as winter looms and we wait for a vaccine, here’s an idea: The government should pay bars, many restaurants and event venues to close for some months. That may sound radical, but it makes scientific sense and even has a political precedent. We pay farmers not to cultivate some fields (in theory, at least, to protect the environment), so why not compensate owners to shut their indoor venues (to protect public health)?
Facing a pandemic, record unemployment and unknown future costs for COVID-19 treatments, health insurers selling Affordable Care Act plans to individuals reacted by lowering rates in some areas and, overall, issuing only modest premium increases for 2021. “What’s been fascinating is that carriers in general are not projecting much impact from the pandemic for their 2021 premium rates,” said Sabrina Corlette, a research professor at the Center on Health Insurance Reforms at Georgetown University in Washington, D.C. Although final rates have yet to be analyzed in all states, those who study the...
If Joe Biden wins the presidency in November, health is likely to play a high-profile role in his agenda. Just probably not in the way he or anyone else might have predicted. Barring something truly unforeseen, it’s fairly certain that on Jan. 20 the U.S. will still be in the grip of the coronavirus pandemic — and the economic dislocation it has caused. Coincidentally, that would put a new President Biden in much the same place as President Barack Obama at his inauguration in 2009: a Democratic administration replacing a Republican one in the midst of a national crisis.
President Donald Trump has repeatedly claimed to have saved 2 million lives from COVID-19 through his actions to combat the disease. Recently, he made the assertion during the NBC News town hall on Oct. 15 that replaced the second presidential debate. “But we were expected to lose, if you look at the original charts from original doctors who are respected by everybody, 2,200,000 people,” Trump said. “We saved 2 million people,” he added.
Donella Pogue has trouble finding dentists in her rural area willing to accommodate her 21-year-old son, Justin, who is 6 feet, 8 inches tall, is on the autism spectrum and has difficulty sitting still when touched. And this summer, he had a cavity and his face swelled. Pogue, of Bristol, New York, reached out to the Eastman Institute for Oral Health in Rochester, which offers teledentistry. Dr. Adela Planerova looked into his mouth from 28 miles away as Pogue pointed her laptop’s camera into her son’s mouth. Planerova determined they did not need to make an emergency one-hour drive to her...
In mid-March, Karla Monterroso flew home to Alameda, California, after a hiking trip in Utah’s Zion National Park. Four days later, she began to develop a bad, dry cough. Her lungs felt sticky. The fevers that persisted for the next nine weeks grew so high — 100.4, 101.2, 101.7, 102.3 — that, on the worst night, she was in the shower on all fours, ice-cold water running down her back, willing her temperature to go down. “That night I had written down in a journal, letters to everyone I’m close to, the things I wanted them to know in case I died,” she remembered.
Journalists from KHN and the Guardian have identified 1,318 workers who reportedly died of complications from COVID-19 they contracted on the job. Reporters are working to confirm the cause of death and workplace conditions in each case. They are also writing about the people behind the statistics — their personalities, passions and quirks — and telling the story of every life lost. Explore the new interactive tool tracking those health worker deaths.
Just 15 days ahead of the election, Montana Lt. Gov. Mike Cooney laid out his ideas on how he’d handle the COVID-19 pandemic if elected governor. Details were few, but the Democrat’s plan became one of only a handful being offered by candidates in the 11 U.S. governor’s races about how they’ll approach what’s certain to be the dominant issue of their terms, should they win.

 

DISCLAIMER: The information found on this Web Site is dynamic and subject to change. Please use the "CONTACT US" section of the Web Site to submit any questions or comments.